middle.news
Imugene Launches $37.5M Equity Raise to Accelerate Azer-Cel Trials
11:11am on Wednesday 16th of July, 2025 AEST
•
Healthcare
Read Story
Imugene Launches $37.5M Equity Raise to Accelerate Azer-Cel Trials
11:11am on Wednesday 16th of July, 2025 AEST
Key Points
Placement to raise $22.5 million at $0.33 per share
Share Purchase Plan targeting $15 million with oversubscription option
Three attaching options per four new shares, exercisable at $0.43
Piggyback options exercisable at $0.86 for every attaching option exercised
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Imugene (ASX:IMU)
OPEN ARTICLE